Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
The benefits of placebo effect
The benefits of placebo effect
The benefits of placebo effect
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Introduction
Clinical trial is a gateway to become proved practical medical treatment, so it requires accuracy and validity of the outcomes. Placebo control trials are therefore employed in clinical trials as nearly half of academic physicians have answered in a questionnaire that they had used a placebo in their clinical trials (Sherman and Hickner, 2007). To have the higher scientific validity of results on the clinical trials require that prospective, carefully selected subjects and endpoints, a control group, randomly allocated subjects into a treatment group and a control group, blinded both subject groups and investigators, sufficient sample size, and an approved independent ethics committee and monitoring by data safety and monitor board to have stronger the scientific validity on the clinical trials (Brody, 1997). The use of placebos will enable to have more scientifically reliable outcome. However, unnecessarily or ineffectiveness of placebo use is also claimed therefore considering appropriate conditions and suitable cases would be needed for placebo use.
.
Legitimacy and justify of placebo use in clinical trial
Employing placebo in clinical trial can improve quality of the study results. Firstly, a placebo group employment enables to evaluate efficacy of blind, randomised subject control medical treatment avoiding assessment bias. Secondly, it can be reduce the number of patients to conduce since outcomes in different states these are treatment group and placebo group can be compared which make the difference clearer whether the results is beneficial or harmful. Thirdly, placebo can be used in addition to normal treatment of patients which results will show genuine result as beneficial or harmful conditional ...
... middle of paper ...
...f patients’ doctors recruited participants, patients may not ease to refuse participating a trial. Therefore recruitment may be better to be done by a person who does not normally treat the patients.
Conclusion
Placebos are currently often employed, effective device to determine significant effect in clinical trials. However, not all kind of clinical trials are suitable for use placebos as which has strong placebo effect and aiming to discover a treatment for a specific diseases of which is restricted due to using placebos for sufficient and prompt investigation. Consequently, appropriate conditions and justifying placebo use is vital as control group in clinical trial, which should be beneficial, safe and valid for patients who are in both treatment and control group. Keeping these in mind and sufficient discovery of medical treatment is highly desired.
...r away from the thread of paternalism because the doctor is not inclined or able to take advantage of the patient.
The IRB is an administrative body which has been established to make sure research participants' rights are protected. IRBs review all aspects of the researchers' project: the study design, the recruitment process, the participant population, the informed consent document and process, the risk/benefit ratio, privacy and confidentiality, data storage and protection, and safeguards for vulnerable participants (University of St. Francis, n.d.). In this way, participants' rights are protected because the effort is made even before the research begins. The review process ensures that participants are chosen fairly and informed adequately and the information collected during research is safeguarded through collection, use, and storage. Research using human participants is such an important part of medicine that it is imperative it is performed in a way that its intrigue is not compromised.
Ernst, E., & Resch, K. L. (1995). Concept of true and perceived placebo effects. British Medical
Video “Stossel Testing Therapeutic touch” (7/17/16). Some things never change like the idea of the placebo effect that is relevant today. A fourth grader conducted a study which proved therapeutic touch was ineffective, yet therapeutic touch is still in used. Scientists say it is still use because if someone believes something like therapeutic touch will work then it may. This is known as a placebo effect. Placebos are extremely relevant today, so much so that they are used in experiments for products to gain the approval of the FDA. FDA approval contains placebos to insure a product actually does what it claims it does, and it is not just working because a group of people believe in the product. In these experiments the placebo group
Although, Marchant is a published writer it does not go into her background and what makes her a credible author in regards to placebos. She also discusses The Kaiser Foundation and does not even give us a brief description of how they are well informed in the matter. When you read an article and may not be informed on the subject matter, to build credibility, you should be able to explain your sources background to help build the credibility and strength of your writing. She mentions several studies and statistics but there is no credibility built to back up any of her sources; it’s written as it’s assumed they are credible. She ineffectively gave credibility to her sources, which makes you question the whole
... be in the patient’s best interest and getting the best results for the trial.
To sum things up, the ethical demeanor of research involves respect for the safety and rights of subjects during the sequence of the trial. This includes protecting privacy and confidentiality, monitoring the condition of research subjects to assure their safety, terminating study participation in the case of hostile events, and notifying enrolled subjects about new risks, benefits, or other information that may bear upon subjects’ decisions to continue enrollment in the research. As new evidence shows itself, trial investigators and data safety monitoring boards (DSMBs) can alter the study plan, initiate notice of enrolled subjects, make changes to the informed consent policies, or stop the trials earlier than intended. Investigators should soon classify a technique for ensuring effective communication between the IRB and DSMB throughout these studies.
In Marcia Angell’s article, “The Ethics of Clinical Research in the Third World,” she strongly argues the use of clinical placebo-controlled trials done in developing countries are unethical if an effective treatment already exists. Angell believes studies that compare potential new treatment with a placebo controlled group is ineffective and unnecessary. All research studies should offer the best standard of care and give participants the most beneficial outcome and treatment possible. The main priority of a study is not the goals of the research itself, but the well-being of the participants. Angell uses many sources to defend her argument, such as WHO.
The placebo effect has been one of the most interesting but irritating topics within biomedical science for over the past 60 years. Through this speech I wish to inform and educate while I discuss the placebo effect and cover what it is, how it works and why that is.
There are some key distinctions between Randomized Controlled Trials (RCT) in a psychotherapeutic context and a medical context. There are key differences between the design of an RCT to evaluate a new drug and an RCT to evaluate a new form of couples’ therapy. However, it is important to begin by defining and understanding the importance of RCT in research (O'Brien, 2013).
6. Were all of the patients who entered the trial properly accounted for at its conclusion?
Informed consent is a very serious decision a patient has to make when it comes to their health and consenting to procedures that are believed to cure or treat their current health status. It is important to address the effectiveness of the role a physician play in the informed consent process assuring that the patient has given truly informed consent and what safeguards can be put in place to assure the patient is exercising informed consent. Informed consent is based on the fact that the person consenting is a rational individual that is aware of the action to which he/she is consenting. Allen and McNamara (2011) notes that "On the standard understanding, the important elements of informed consent are the provision of information, the voluntariness of the choice and the competence of the chooser to make the choice— so the potential research participant should be provided with information relevant to the decision to participate, they should be able to choose freely about their participation and they should be competent to decide.
Turner, B. J., Newschaffer, C. J., Zhang, D., Fanning, T., & Hauck, W. W. (1999). Translating clinical trial results into practice. Annals of Internal Medicine, 130(12), 979-986.
Miller, F. (2003). Therapeutic Misconception in the Ethics of Clinical Trials,. The Hastings Center Report.
The recruitment and retention department in the health care department aims to increase the supply of needed health professionals and revitalize he current and future healthcare workforce. The recruitment and retention department is responsible for increasing interest in healthcare careers, both generally and specific areas of shortage. The recruitment and retention department aims to reduce many barriers they may have in the healthcare professionals. And finally they can make everyone’s work environment healthier.